mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.014 |
0.9 |